Platelet counts for predicting survival in sepsis patients
Part of Infections clinical trials.
This study looks at whether platelet counts (a type of blood cell that helps clotting) can predict how likely a patient is to survive sepsis. If you are hospitalized with sepsis, your platelet levels may be measured to see if they can help doctors know who needs more intensive care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in the hospital (including the ICU) with sepsis—a severe infection that affects your organs.
- You cannot have received a platelet transfusion within the 24 hours before the first blood test.
- You cannot have a blood cancer requiring active chemotherapy or chronic low platelets from other causes.
- You must be willing to allow your medical records to be reviewed for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This trial tests a drug called romiplostim to see if it can safely raise platelet counts in people with sepsis (a severe infection that can cause organ damage). If you have low platelets due to sepsis, this treatment might help reduce bleeding risks.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This study looks at whether simple blood tests can help predict if people who have had sepsis will have thinking or memory problems later. If you are in the ICU with sepsis, this trial might help doctors understand your risk for long-term brain issues.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.